Truveta brand logo mark in teal on a black background, featuring stacked chevron shapes forming the Truveta symbol.
Close

Saving Lives with Data

Where yesterday's care becomes today's intelligence

Get started

Truveta Data

The most complete, real-time view of US healthcare

140M+

Patients and growing

Updated daily

Longitudinally linked:

EHR
Closed claims
Devices
Images
SDOH
Mother-child
Multiomics
Mortality
Explore Truveta Data

Truveta Intelligence

Bring Truveta Data to every healthcare decision

Explore Truveta Intelligence
Explore Truveta Intelligence

Truveta Evidence

Build trust through rigorous analytics and expertise

Trusted research environment

Deliver transparent, auditable results
Generate regulatory-grade evidence within existing workflows, backed by complete end-to-end provenance
Continuously validate findings as data and assumptions evolve
Explore Truveta Evidence

Truveta Evidence Services

Accelerate regulatory-grade evidence with end-to-end study design and delivery

Extend capacity with trusted experts
Accelerate timelines from protocol to submission
Maximize value from real-world data
De-risk high-impact regulatory and post-market studies
Learn more
350+

Publications

250+

Conference presentations

150K+

Citations

100+

Regulatory projects across US and global agencies

Learn more

The knowledge layer for US healthcare

Learn from every patient, understand what’s changing as it happens, and move healthcare forward with complete data

Safety

Uncover adverse events faster

Therapy adoption

Track patient access and industry trends as care happens

AI training and validation

Develop models with deep, multimodal data

Healthcare optimization

Optimize care delivery and outcomes

Clinical trials

Accelerate patient recruitment and site enrollment

Outcomes research

Quantify cost and effectiveness with unmatched depth and precision

Built with US health systems

Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Meet our members
Pharmaceutical
Medical device
Healthcare
Government
Technology
Financial services

Ready for the entire healthcare ecosystem

Ready for the entire healthcare ecosystem

Pharmaceutical
Medical device
Healthcare
Government
Technology
Financial services

Trusted by leading life science, government, technology, and healthcare organizations

Moderna
Boehringer Ingleheim
Providence
Boston Scientific
CommonSpirit
SK
Medcomp
Advocate
Northwell

Featured research

C-section pain management study thumbnail image in Truveta branding.

Pain management after C-section: Following the journey from hospital to home

Pain medication use was nearly universal in the hospital, with more than 9 in 10 C-sections including acetaminophen, an NSAID, and an opioid. After discharge, NSAIDs and opioids were prescribed after about 6 in 10 C-sections and acetaminophen after about half. The...
Rising rate of non-receipt of vitamin K for newborns, January 2019–June 2026

Rising rate of non-receipt of vitamin K for newborns, 2019–June 2026

Truveta Research finds documented newborn vitamin K non-receipt rose from 5.2% in January to 8.1% in June 2026, continuing a recent upward trend.

Graphic from Truveta showing a record increase in GLP-1 prescribing among older adults following the launch of Medicare's GLP-1 Bridge program, with trend lines illustrating prescribing growth over time.

Older adults see record increase in GLP-1 prescribing following Medicare GLP-1 Bridge program

New Truveta research shows GLP-1 prescribing among adults 65+ rose 19% in July 2026, a record increase after Medicare’s GLP-1 Bridge launch.

Truveta research graphic titled '2026 Cyclosporiasis Outbreak: Diagnoses Reach Historic Levels,' featuring outbreak trend lines that illustrate a significant rise in cyclospora diagnoses during summer 2026

Cyclosporiasis diagnoses reach historic levels in 2026 summer outbreak

Real-world data reveal record cyclosporiasis diagnoses during the 2026 summer outbreak and support faster outbreak monitoring.

C-section pain management study thumbnail image in Truveta branding.

Pain management after C-section: Following the journey from hospital to home

Rising rate of non-receipt of vitamin K for newborns, January 2019–June 2026

Rising rate of non-receipt of vitamin K for newborns, 2019–June 2026

Graphic from Truveta showing a record increase in GLP-1 prescribing among older adults following the launch of Medicare's GLP-1 Bridge program, with trend lines illustrating prescribing growth over time.

Older adults see record increase in GLP-1 prescribing following Medicare GLP-1 Bridge program

Truveta research graphic titled '2026 Cyclosporiasis Outbreak: Diagnoses Reach Historic Levels,' featuring outbreak trend lines that illustrate a significant rise in cyclospora diagnoses during summer 2026

Cyclosporiasis diagnoses reach historic levels in 2026 summer outbreak

Find more research

Featured in

Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Brand Name
Visit the newsroom

Follow us on LinkedIn to keep up with the latest from Truveta

Follow us